Skip to main content

Table 2 Overview of prescribed inhaler devices used by 105 patients at the time of the survey

From: Inhaler devices in asthma and COPD patients – a prospective cross-sectional study on inhaler preferences and error rates

Inhaler device Total number of patients, n (%) Proportion within asthma patients, % Proportion within COPD patients, %
Breezhaler® 18 (9.84) 0.99 20.73
Diskus® 9 (4.92) 7.92 1.22
Pressurized metered-dose inhaler (pMDI) 72 (39.34) 46.53 30.49
Elpenhaler® 1 (0.55) 0 1.22
Forspiro® 1 (0.55) 0 1.22
Genuair® 9 (4.92) 3.96 6.10
Nexthaler® 7 (3.83) 4.95 2.44
Respimat® 19 (10.38) 10.89 9.76
Spiromax® 3 (1.64) 0.99 2.44
Turbohaler® 31 (16.94) 21.78 10.98
None of the above 12 (6.56) 1.98 12.20
No device was currently used 1 (0.55) 0 1.22